参考文献/References:
[1]Wang YJ,Li ZX,Gu HQ,et al.China Stroke Statistics 2019:A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations[J].Stroke Vasc Neurol,2020,5(3):211-239.[2]Moretti R,Caruso P.The Controversial Role of Homocysteine in Neurology: From Labs to Clinical Practice[J].Int J Mol Sci,2019,20(1):231.[3]Tu W,Yan F,Chao B,et al.Status of hyperhomocysteinemia in China: results from the China Stroke High-risk Population Screening Program,2018[J].Frontiers of Medicine,2021,15(6):903-912.[4]Song Y,Li B,Wang C,et al.Association between 5,10-Methylenetetrahydrofolate Reductase C677T Gene Polymorphism and Risk of Ischemic Stroke: A Meta-analysis[J].Journal of Stroke and Cerebrovascular Diseases,2016,25(3):679-687.[5]Chen M,Mao BY,Wang D,et al.Association between rs1801133 polymorphism and risk of adult ischemic stroke: Meta-analysis based on case-control studies[J].Thrombosis Research,2016,137:17-25.[6]Kang S,Zhao X,Liu L,et al.Association of the C677T polymorphism in the MTHFR gene with hemorrhagic stroke: a meta-analysis[J].Genet Test Mol Biomarkers,2013,17(5):412-417.[7]Lv QQ,Lu J,Sun H,et al.Association of methylenetetrahydrofolate reductase (MTHFR) gene polymorphism with ischemic stroke in the Eastern Chinese Han population[J].Genetics and Molecular Research,2015,14(2):4161-4168.[8]Abidi O,Haissam M,Nahili H,et al.Methylenetetrahydrofolate Reductase Gene Polymorphisms (C677T and A1298C) and Hemorrhagic Stroke in Moroccan Patients [J].Journal of Stroke and Cerebrovascular Diseases,2018,27(7):1837-1843.[9]Frosst P,Blom HJ,Milos R,et al.A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase[J].Nature genetics,1995,10(1):111-113.[10]Mazdeh M,Khazaie M,Omrani MD,et al.Association between methylene tetrahydrofolate reductase polymorphisms and risk of ischemic stroke[J].The International Journal of Neuroscience,2021,131(1):44-48.[11]Dribnokhodova OP,Korchagin VI,Mironov KO,et al.A comparative analysis of allele frequencies of rs1801133 and rs1801131 of MTHFR in patients with stroke and healthy people from the Moscow region[J].Zh Nevrol Psikhiatr Im S S Korsakova,2019,119(3.Vyp.2):18-23.[12]Arsene D,G?觍in?觍 G,B?觍lescu C,et al.C677T and A1298C methylenetetrahydropholate reductase (MTHFR) polymorphisms as factors involved in ischemic stroke[J].Rom J Morphol Embryol,2011,52(4):1203-1207.[13]Huang LW,Li LL,Li J,et al.Association of the methylenetetrahydrofolate reductase (MTHFR) gene variant C677T with serum homocysteine levels and the severity of ischaemic stroke: a case-control study in the southwest of China[J].J Int Med Res,2022,50(2):3000605221081632.[14]徐永华,刘艳秋,张兆振,等.江西地区育龄女性HCY水平及其亚甲基四氢叶酸还原酶基因多态性分析[J].江西医药,2020,55(2):163-165.[15]Kuriakose D,Xiao Z.Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives[J].International Journal of Molecular Sciences,2020,21(20):7609.[16]Feng C,Yang Y,Yang S,et al.Effect of gene-gene and gene-environment interaction on the risk of first-ever stroke and poststroke death[J].Molecular Genetics & Genomic Medicine,2019,7(8):e846.[17]Harbuzova V,Polonikov OV,Stroǐ DO,et al.Analysis of the effect of N5, N10-methylenetetrahydrofolate reductase gene C(677)-->T polymorphism on the ischemic stroke development in persons with various risk factors[J].Fiziolohichnyi Zhurnal,2014,60(2):18-24.[18]Huang X,Qin X,Yang W,et al.MTHFR Gene and Serum Folate Interaction on Serum Homocysteine Lowering: Prospect for Precision Folic Acid Treatment[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2018,38(3):679-685.[19]Jiang S,Li J,Zhang Y,et al.Methylenetetrahydrofolate reductase C677T polymorphism, hypertension and risk of stroke: a prospective, nested case-control study [J].The International Journal of Neuroscience,2017,127(3):253-260.[20]Pang H,Fu Q,Cao Q,et al.Sex differences in risk factors for stroke in patients with hypertension and hyperhomocysteinemia[J].Scientific Reports,2019,9(1):14313.
相似文献/References:
[1]余 亮,谭自明,张 斌,等.甘露糖结合凝集素基因多态性与结核病易感性关系的研究[J].医学信息,2018,31(13):65.[doi:10.3969/j.issn.1006-1959.2018.13.019]
YU Liang,TAN Zi-ming,ZHANG Bin,et al.Relationship between Polymorphism of Mannose Binding Lectin Gene and Susceptibility to Tuberculosis[J].Journal of Medical Information,2018,31(20):65.[doi:10.3969/j.issn.1006-1959.2018.13.019]
[2]王在川,华 琳.SOD基因多态性与COPD易感性的Meta分析[J].医学信息,2018,31(17):57.[doi:10.3969/j.issn.1006-1959.2018.17.018]
WANG Zai-chuan,HUA Lin.Meta-analysis of SOD Gene Polymorphism and Susceptibility to COPD[J].Journal of Medical Information,2018,31(20):57.[doi:10.3969/j.issn.1006-1959.2018.17.018]
[3]罗翠竹,王小明,周 云.MTHFR C677T多态性与脓毒血症的关系[J].医学信息,2019,32(21):101.[doi:10.3969/j.issn.1006-1959.2019.21.031]
LUO Cui-zhu,WANG Xiao-ming,ZHOU Yun.Relationship between MTHFR C677T Polymorphism and Sepsis[J].Journal of Medical Information,2019,32(20):101.[doi:10.3969/j.issn.1006-1959.2019.21.031]
[4]朱红涛,丁振江,赵媛媛.CYP2C19基因多态性与氯吡格雷抵抗的相关性研究[J].医学信息,2020,33(08):40.[doi:10.3969/j.issn.1006-1959.2020.08.014]
ZHU Hong-tao,DING Zhen-jiang,ZHAO Yuan-yuan,et al.Correlation Between CYP2C19 Gene Polymorphism and Clopidogrel Resistance[J].Journal of Medical Information,2020,33(20):40.[doi:10.3969/j.issn.1006-1959.2020.08.014]
[5]陈启松,何海军,谷光敏,等.IL-6基因多态性与心房颤动相关性的Meta分析[J].医学信息,2020,33(23):73.[doi:10.3969/j.issn.1006-1959.2020.23.021]
CHEN Qi-song,HE Hai-jun,GU Guang-min,et al.Meta Analysis of the Correlation Between IL-6 Gene Polymorphism and Atrial Fibrillation[J].Journal of Medical Information,2020,33(20):73.[doi:10.3969/j.issn.1006-1959.2020.23.021]
[6]张莹莹,郭绪昆,刘 寅.氯吡格雷药代动力学特点及其在心血管疾病中的临床应用[J].医学信息,2021,34(20):45.[doi:10.3969/j.issn.1006-1959.2021.20.011]
ZHANG Ying-ying,GUO Xu-kun,LIU Yin.Pharmacokinetic Characteristics of Clopidogrel and the Clinical Application in Cardiovascular Diseases[J].Journal of Medical Information,2021,34(20):45.[doi:10.3969/j.issn.1006-1959.2021.20.011]
[7]赵鑫龙,杨杰孚.华法林药物基因组学的应用[J].医学信息,2021,34(20):50.[doi:10.3969/j.issn.1006-1959.2021.20.012]
ZHAO Xin-long,YANG Jie-fu.Application of Warfarin Pharmacogenomics[J].Journal of Medical Information,2021,34(20):50.[doi:10.3969/j.issn.1006-1959.2021.20.012]
[8]曾 意,汤永红,张 平.CYP2C19基因多态性与复发性缺血性卒中关系的研究[J].医学信息,2022,35(11):22.[doi:10.3969/j.issn.1006-1959.2022.11.007]
ZENG Yi,TANG Yong-hong,ZHANG Ping.Study on Correlation Between CYP2C19 Gene Polymorphism and Recurrent Ischemic Stroke[J].Journal of Medical Information,2022,35(20):22.[doi:10.3969/j.issn.1006-1959.2022.11.007]
[9]邹光美,黄朝任.白介素6基因多态性与多种疾病的相关性研究[J].医学信息,2022,35(12):61.[doi:10.3969/j.issn.1006-1959.2022.12.014]
ZOU Guang-mei,HUANG Chao-ren.Correlation Between Interleukin 6 Gene Polymorphism and Various Diseases[J].Journal of Medical Information,2022,35(20):61.[doi:10.3969/j.issn.1006-1959.2022.12.014]
[10]邓顺顺,平军娇,章 杰,等.APOE基因多态性与精神分裂症的相关性研究[J].医学信息,2023,36(06):110.[doi:10.3969/j.issn.1006-1959.2023.06.024]
DENG Shun-shun,PING Jun-jiao,ZHANG Jie,et al.Study on the Correlation Between APOE Gene Polymorphism and Schizophrenia[J].Journal of Medical Information,2023,36(20):110.[doi:10.3969/j.issn.1006-1959.2023.06.024]